Intellia amends bylaws to adopt majority voting for uncontested director elections

Intellia Therapeutics, Inc.

Majority vote standard adopted for uncontested director elections; plurality retained for contested elections.
Amended bylaws include proxy solicitation procedures consistent with SEC Rule 14a-19.
Changes effective April 3, 2025; Board approved on recommendation of governance committee.
Other clarifying and procedural amendments also made to the bylaws.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.